COVID 19: We are open for in-office and virtual visits. Read our safety precautions.

Botox competitor, Xeomin, coming to Los Angeles

Move over Botox and Dysport!  A third player is coming to town.

Xeomin, another botulinum toxin, just got FDA approval for the treatment of wrinkles.  Approval was based on two clinical trials in the U.S. involving 547 healthy adults.  Xeomin is already approved and used in Europe for the treatment of wrinkles.

Xeomin should be available in Los Angeles in the spring of 2012.

The cost of Xeomin remains to be determined.

Botox was the original botulinum toxin approved for the treatment of frown lines and is the most widely used.  Dysport has been available for about 2 years.

{ 0 comments… add one }

Leave a Comment

Dr. Osman's Media & Awards